Patient-Reported Outcome Labeling for Cardiovascular Drugs Approved in the United States: 2011-2017

被引：0
|
作者：
Zettler, Marjorie E. [1 ]
Lieu, Hsiao [2 ]
机构：
[1] Cardinal Hlth Specialty Solut, Regulatory Sci, Overland Pk, KS USA
[2] Genentech Inc, OMNI, GRED Early Clin Dev, San Francisco, CA 94080 USA
来源：
CIRCULATION | 2018年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10649
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Patient-Reported Outcome Labeling for Malignant Hematology Drugs Approved in the United States: 2011-2017
    Zettler, Marjorie E.
    Basch, Ethan
    Nabhan, Chadi
    BLOOD, 2018, 132
  • [2] Patient-Reported Outcome Labeling for Antidiabetic Agents Approved in the United States, 2011-2017
    Zettler, Marjorie E.
    Sandoval, Renato
    DIABETES, 2018, 67
  • [3] PATIENT-REPORTED OUTCOME LABELING FOR GASTROINTESTINAL DRUGS APPROVED IN THE UNITED STATES: 2011-2016
    Zettler, Marjorie E.
    Lim, Joel D.
    GASTROENTEROLOGY, 2018, 154 (06) : S999 - S999
  • [4] PATIENT-REPORTED OUTCOME LABELING FOR RHEUMATOID ARTHRITIS DRUGS APPROVED IN THE UNITED STATES: 2010-2019
    Zettler, M.
    Brown-Bickerstaff, C.
    Savill, K.
    Gajra, A.
    Feinberg, B.
    VALUE IN HEALTH, 2021, 24 : S142 - S143
  • [5] A Review of Patient-Reported Outcome Labeling in the United States (2011-2015)
    Gnanasakthy, Ari
    Mordin, Margaret
    Evans, Emily
    Doward, Lynda
    DeMuro, Carla
    VALUE IN HEALTH, 2017, 20 (03) : 420 - 429
  • [6] Recent trends in the inclusion of patient-reported outcome (PRO) data in approved drugs labeling by FDA and EMEA
    Caron, M.
    Emery, M. P.
    Marquis, P.
    Piault, E.
    VALUE IN HEALTH, 2008, 11 (03) : A54 - A54
  • [7] UPDATE OF TRENDS IN THE INCLUSION OF PATIENT-REPORTED OUTCOME (PRO) DATA IN APPROVED DRUGS LABELING BY FDA AND EMEA
    Caron, M.
    Emery, M. P.
    Marquis, P.
    Piault, E.
    VALUE IN HEALTH, 2008, 11 (06) : A574 - A574
  • [8] A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021)
    Gnanasakthy, Ari
    Levy, Courtney
    Norcross, Lindsey
    Doward, Lynda
    Winnette, Randall
    VALUE IN HEALTH, 2023, 26 (06) : 893 - 901
  • [9] Surrogate End Points and Patient-Reported Outcomes for Novel Oncology Drugs Approved Between 2011 and 2017
    Zettler, Marjorie
    Basch, Ethan
    Nabhan, Chadi
    JAMA ONCOLOGY, 2019, 5 (09) : 1358 - 1359
  • [10] Patient-reported outcome measures in drugs for neurological conditions approved by European Medicines Agency 2017–2022
    Oriana Ciani
    Michela Meregaglia
    Mario Alberto Battaglia
    Gianpaolo Brichetto
    Antonella Conte
    Claudio Gasperini
    Valeria Sansone
    Neurological Sciences, 2023, 44 : 2933 - 2937
12345